Evidence map›Paper›PMID 31940343›Full record

ArticlePLoS neglected tropical diseases2020

Madurella real-time PCR, a novel approach for eumycetoma diagnosis.

Amir Arastehfar, Wilson Lim, Farnaz Daneshnia, Wendy W J van de Sande, Ahmed H Fahal, Marie Desnos-Ollivier, Gerrit S de Hoog, Teun Boekhout, Sarah A Ahmed

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. A qPCR identification scheme to differentiate actinomycetoma from eumycetoma.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Subcutaneous Mycoses in Travelers.Current tropical medicine reports · 2020
    Article
  9. Identification of Mycoses in Developing Countries.Journal of fungi (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Amir ArastehfarWesterdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.ORCID 0000-0002-4361-4841
Wilson LimErasmus MC, University Medical Center Rotterdam, Department of Microbiology and Infectious Diseases, Rotterdam, The Netherlands.
Farnaz DaneshniaWesterdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.
Wendy W J van de SandeErasmus MC, University Medical Center Rotterdam, Department of Microbiology and Infectious Diseases, Rotterdam, The Netherlands.
Ahmed H FahalMycetoma Research Centre, University of Khartoum, Khartoum, Sudan.
Marie Desnos-OllivierInstitut Pasteur, Molecular Mycology Unit, National Reference Center for Invasive Mycoses and Antifungals, CNRS UMR2000, Paris, France.
Gerrit S de HoogWesterdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.
Teun BoekhoutWesterdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.
Sarah A AhmedWesterdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genus Madurella comprising four species, M. fahalii, M. mycetomatis, M. pseudomycetomatis, and M. tropicana, represents the prevalent cause of eumycetoma worldwide. The four species are phenotypically similar and cause an invariable clinical picture, but differ markedly in their susceptibility to antifungal drugs, and epidemiological pattern. Therefore, specific identification is required for optimal management of Madurella infection and to reveal proper epidemiology of the species. In this study, a novel multiplex real-time PCR targeting the four Madurella species was developed and standardized. Evaluation of the assay using reference strains of the target and non-target species resulted in 100% specificity, high analytical reproducibility (R2 values >0.99) and a lowest detection limit of 3 pg target DNA. The accuracy of the real-time PCR was further assessed using biopsies from eumycetoma suspected patients. Unlike culture and DNA sequencing as gold standard diagnostic methods, the real-time PCR yielded accurate diagnosis with specific identification of the causative species in three hours compared to one or two weeks required for culture. The novel method reduces turnaround time as well as labor intensity and high costs associated with current reference methods.

Indexed as

BiopsyDNA, FungalHumansMadurellaMycetomaReal-Time Polymerase Chain ReactionSensitivity and SpecificityDNA, Fungal

Identifiers

PMID31940343
PMCPMC6986762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.